After Trading of Parenteral Drugs’ Goa Unit, Stocks Fall

by Paul Joseph on March 15, 2013 · 0 comments

After the company sold its subsidiary’s Goa unit to Fresenius Kabi, Parenteral Drugs (India) has met with a dip in its stocks by 18%. Parenteral Drugs India Ltd. has signed an agreement with Fresenius Kabi India Pvt. Ltd. to trade one of its domestic pharmaceutical manufacturing units located in Goa. It has been sold at Rs. 200 crore ($36.78 million). Fresenius Kabi India is a fully owned subsidiary of Fresenius Kabi AG, a part of the Fresenius Health Care Group. The company is headquartered in Bad Homburg, Germany. Systematix Capital Services has been the advisor in this deal. read more

[via Stock Watch – Stock Specific News]

Follow us @enterpriseheat – lists / @sectorheat

Follow us @enterpriseheat - lists / @sectorheat

Leave a Comment

Previous post:

Next post: